2-({6-[5-Methyl-1-(4-methylphenyl)-1H-1,2,3-triazol-4-yl]imidazo[2,1-b]thiazol-5-yl}methylidene)hydrazinecarbothioamide dimethylformamide 0.25-solvate

The asymmetric unit of the title solvate, C17H16N8S2·0.25C3H7NO, consists of two C17H16N8S2 molecules and a dimethylformamide molecule disordered about a crystallographic inversion centre. Both triazole molecules feature an intramolecular C—H...N interaction, which generates an S(6) ring in each cas...

Full description

Bibliographic Details
Main Authors: Gamal A. El-Hiti, Bakr F. Abdel-Wahab, Mohammad Hayal Alotaibi, Amany S. Hegazy, Benson M. Kariuki
Format: Article
Language:English
Published: International Union of Crystallography 2018-01-01
Series:IUCrData
Subjects:
Online Access:http://scripts.iucr.org/cgi-bin/paper?S2414314618000871
Description
Summary:The asymmetric unit of the title solvate, C17H16N8S2·0.25C3H7NO, consists of two C17H16N8S2 molecules and a dimethylformamide molecule disordered about a crystallographic inversion centre. Both triazole molecules feature an intramolecular C—H...N interaction, which generates an S(6) ring in each case. In the crystal, the components are linked by N—H...N and N—H...S hydrogen bonds to form [001] chains, which are cross-linked by weak C—H...O, C—H...N and C—H...S interactions.
ISSN:2414-3146